Perrin LH - Search Results

1

A placebo-controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infection. The Swiss HIV Cohort Study.

Rutschmann OT, Opravil M, Iten A, Malinverni R, Vernazza PL, Bucher HC, Bernasconi E, Sudre P, Leduc D, Yerly S, Perrin LH, Hirschel B. Rutschmann OT, et al. Among authors: perrin lh. AIDS. 1998 May 28;12(8):F71-7. doi: 10.1097/00002030-199808000-00003. AIDS. 1998. PMID: 9631134 Clinical Trial.

2

A controlled trial of granulocyte macrophage-colony stimulating factor during interruption of HAART.

Fagard C, Le Braz M, Günthard H, Hirsch HH, Egger M, Vernazza P, Bernasconi E, Telenti A, Ebnöther C, Oxenius A, Perneger T, Perrin L, Hirschel B; Swiss HIV Cohort Study. Fagard C, et al. AIDS. 2003 Jul 4;17(10):1487-92. doi: 10.1097/00002030-200307040-00009. AIDS. 2003. PMID: 12824786 Clinical Trial.

3

CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.

Kaufmann GR, Perrin L, Pantaleo G, Opravil M, Furrer H, Telenti A, Hirschel B, Ledergerber B, Vernazza P, Bernasconi E, Rickenbach M, Egger M, Battegay M; Swiss HIV Cohort Study Group. Kaufmann GR, et al. Arch Intern Med. 2003 Oct 13;163(18):2187-95. doi: 10.1001/archinte.163.18.2187. Arch Intern Med. 2003. PMID: 14557216

4

Early and prolonged decrease of viremia in HIV-1-infected patients treated with didanosine.

Yerly S, Kaiser L, Baumberger C, Hirschel B, Perrin LH. Yerly S, et al. Among authors: perrin lh. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Apr 1;8(4):358-64. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 7882100

5

Didanosine plus stavudine with or without hydroxyurea in HIV-1-infected patients: 1 year follow-up. Swiss HIV Cohort Study.

Rutschmann OT, Opravil M, Iten A, Malinverni R, Vernazza PL, Bucher H, Bernasconi E, Perrin LH, Yerly S, Hirschel B. Rutschmann OT, et al. Among authors: perrin lh. Antivir Ther. 1998;3 Suppl 4:65-7. Antivir Ther. 1998. PMID: 10723515 Clinical Trial.

6

Response of HIV RNA to didanosine as a predictive marker of survival.

Yerly S, Kaiser L, Mermillod B, Baumberger C, Hirschel B, Perrin L. Yerly S, et al. AIDS. 1995 Feb;9(2):159-63. AIDS. 1995. PMID: 7718186

7

High levels of circulating RNA in patients with symptomatic HIV-1 infection.

Baumberger C, Kinloch-de-Loës S, Yerly S, Hirschel B, Perrin L. Baumberger C, et al. AIDS. 1993 Nov;7 Suppl 2:S59-64. doi: 10.1097/00002030-199311002-00013. AIDS. 1993. PMID: 7909226

8

Prognostic value of viremia in patients with long-standing human immunodeficiency virus infection. Swiss HIV Cohort Study Group.

Galetto-Lacour A, Yerly S, Perneger TV, Baumberger C, Hirschel B, Perrin L. Galetto-Lacour A, et al. J Infect Dis. 1996 Jun;173(6):1388-93. doi: 10.1093/infdis/173.6.1388. J Infect Dis. 1996. PMID: 8648210

9

Acute HIV infection.

Perrin L, Yerly S. Perrin L, et al. J Biol Regul Homeost Agents. 1995 Jul-Sep;9(3):95-9. J Biol Regul Homeost Agents. 1995. PMID: 8782015 Review.

10

Combined therapy with zidovudine and L-697,661 in primary HIV infection.

Perrin L, Rakik A, Yerly S, Baumberger C, Kinloch-de Loës S, Pechère M, Hirschel B. Perrin L, et al. AIDS. 1996 Sep;10(11):1233-7. doi: 10.1097/00002030-199609000-00009. AIDS. 1996. PMID: 8883585

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

264 results

Search Page

Filters